To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TCV buys majority stake in Oversight from Luminate Capital, GHO to buy out Ardian’s stake in Envision Pharma, Audax Group runs broad secondary recap on 2012 fund
GHO Capital agreed to buy out Ardian's stake in Envision Pharma Group and secondaries are poised for a busy fall.
